We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

105 hedge funds and large institutions have $146M invested in Cytokinetics in 2015 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 35 increasing their positions, 32 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

279% more call options, than puts

Call options by funds: $4.32M | Put options by funds: $1.14M

46% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 13

6% more funds holding

Funds holding: 99 → 105 (+6)

9% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 32

4% more capital invested

Capital invested by funds: $140M → $146M (+$6.04M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
105
Holders Change
+6
Holders Change %
+6.06%
% of All Funds
2.93%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
19
Increased
35
Reduced
32
Closed
13
Calls
$4.32M
Puts
$1.14M
Net Calls
+$3.18M
Net Calls Change
+$2.98M

Top Buyers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
+$4.23M
2
Morgan Stanley
Morgan Stanley
New York
+$3.24M
3
Invesco
Invesco
Georgia
+$2.47M
4
KCM
Kennedy Capital Management
Missouri
+$2.38M
5
OAM
Oxford Asset Management
United Kingdom
+$1.43M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$7.18M
2
TC
TFS Capital
Pennsylvania
-$3.64M
3
FLAM
First Light Asset Management
Minnesota
-$1.47M
4
NI
Numeric Investors
Massachusetts
-$1.46M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$811K
Name Holding Trade Value Shares
Change 		Change in
Stake
GC
101
Globeflex Capital
California
$1K – – –
SEI Investments
102
SEI Investments
Pennsylvania
$1K +$546 +80 New
Northwestern Mutual Wealth Management
103
Northwestern Mutual Wealth Management
Wisconsin
$1K +$1.09K +160 New
TRCT
104
Tower Research Capital (TRC)
New York
$1K +$1.19K +174 New
Manulife (Manufacturers Life Insurance)
105
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$169 +$5.22K +765 +3%
FLAM
106
First Light Asset Management
Minnesota
– -$1.47M -218,792 Closed
TI
107
Trexquant Investment
Connecticut
– -$378K -56,300 Closed
RFC
108
Russell Frank Company
Washington
– -$222K -33,033 Closed
SCM
109
Stevens Capital Management
Pennsylvania
– -$199K -29,563 Closed
Ameriprise
110
Ameriprise
Minnesota
– -$110K -16,365 Closed
AL
111
Airain Ltd
Guernsey
– -$80K -11,888 Closed
PC
112
Palo Capital
California
– -$77K -11,526 Closed
ZIM
113
Zacks Investment Management
Illinois
– -$68K -10,172 Closed
JG
114
Jefferies Group
New York
– -$30K -4,417 Closed
CCMH
115
Cornerstone Capital Management Holdings
New York
– -$10K -1,550 Closed
ST
116
Spot Trading
Illinois
– -$7.47K -1,094 Closed
VIA
117
Vantage Investment Advisors
Pennsylvania
– -$7K -1,000 Closed
RIA
118
Regal Investment Advisors
Michigan
– -$2K -404 Closed
1 2 3 4
5

CYTK Hedge Fund Activity: Q3 2015 in Review

105 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q3 2015, worth a combined $146M — up 4.3% from $140M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new CYTK positions and 13 closed out — a net gain of 6 holders — while 35 added to existing stakes and 32 trimmed.

The largest buyer was Citigroup, adding an estimated $4.23M. The largest seller was Fidelity Investments, cutting an estimated $7.18M.

  • 105 institutional investors held Cytokinetics (CYTK) as of Q3 2015, up from 99 in Q2 2015.
  • Funds reported $146M of Cytokinetics stock for Q3 2015, up 4.3% quarter-over-quarter.
  • 19 funds opened new Cytokinetics positions in Q3 2015 and 13 closed out, a net change of +6 holders.
  • The largest Cytokinetics buyer in Q3 2015 was Citigroup, an estimated $4.23M added.
  • The largest Cytokinetics seller in Q3 2015 was Fidelity Investments, an estimated $7.18M sold.

Based on aggregated 13F filings for Q3 2015.